memantine has been researched along with Cerebrovascular Disorders in 10 studies
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Assessing these factors, I discuss how treatable vascular dementia presently is." | 2.53 | [How Treatable is Vascular Dementia?]. ( Mori, E, 2016) |
| "Memantine has been used clinically in the treatment of Parkinson's disease and spasticity for a number of years." | 1.30 | Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. ( Le, DA; Lipton, SA; Sathi, S; Stieg, PE; Warach, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, K | 1 |
| Ikeda, K | 1 |
| Mizumura, S | 1 |
| Tachiki, K | 1 |
| Yanagihashi, M | 1 |
| Iwasaki, Y | 1 |
| Takahashi, H | 1 |
| Xia, P | 1 |
| Cui, J | 1 |
| Talantova, M | 1 |
| Bodhinathan, K | 1 |
| Li, W | 2 |
| Saleem, S | 1 |
| Holland, EA | 1 |
| Tong, G | 1 |
| Piña-Crespo, J | 1 |
| Zhang, D | 1 |
| Nakanishi, N | 1 |
| Larrick, JW | 1 |
| McKercher, SR | 1 |
| Nakamura, T | 1 |
| Wang, Y | 2 |
| Lipton, SA | 2 |
| Mori, E | 1 |
| Chen, B | 1 |
| Wang, G | 1 |
| Liu, W | 1 |
| Lin, R | 1 |
| Tao, J | 1 |
| Jiang, M | 1 |
| Chen, L | 1 |
| Gudkova, AA | 1 |
| Sorokina, IB | 1 |
| Iakovlev, AA | 1 |
| Guliaeva, NV | 1 |
| Gekht, AB | 1 |
| Mao, FX | 1 |
| Li, WJ | 1 |
| Chen, HJ | 1 |
| Qian, LH | 1 |
| Buzby, JS | 1 |
| Bowler, JV | 1 |
| Birks, J | 1 |
| Flicker, L | 1 |
| Stieg, PE | 1 |
| Sathi, S | 1 |
| Warach, S | 1 |
| Le, DA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Memantine for Enhanced Stroke Recovery[NCT02144584] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2014-01-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for memantine and Cerebrovascular Disorders
| Article | Year |
|---|---|
[How Treatable is Vascular Dementia?].
Topics: Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Human | 2016 |
Investigational treatment for vascular cognitive impairment.
Topics: Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Drugs | 2007 |
1 trial available for memantine and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Akatinol memantine in patients with vascular cognitive disorders].
Topics: Aged; Aged, 80 and over; Cerebrovascular Disorders; Cognition; Cognition Disorders; Excitatory Amino | 2010 |
7 other studies available for memantine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Combined treatment of methylprednisolone pulse and memantine hydrochloride prompts recovery from neurological dysfunction and cerebral hypoperfusion in carbon monoxide poisoning: a case report.
Topics: Antiparkinson Agents; Carbon Monoxide Poisoning; Cerebrovascular Circulation; Cerebrovascular Disord | 2014 |
Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease.
Topics: Animals; Anura; Apoptosis; Brain Ischemia; Cerebrovascular Disorders; Long-Term Potentiation; Maze L | 2015 |
Memantine attenuates cell apoptosis by suppressing the calpain-caspase-3 pathway in an experimental model of ischemic stroke.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Brain Ischemia; Calpain; Caspase 3; Cerebral Arteries; C | 2017 |
Periventricular leukomalacia long-term prognosis may be improved by treatment with UDP-glucose, GDNF, and memantine in neonatal rats.
Topics: Animals; Animals, Newborn; Cerebral Ventricles; Cerebrovascular Disorders; Drug Therapy, Combination | 2012 |
Vascular cognitive impairment.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cerebrovascular Disorders; Cholinesterase Inhibito | 2004 |
Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
Topics: AIDS Dementia Complex; Alzheimer Disease; Cerebrovascular Disorders; Clinical Trials as Topic; Excit | 1997 |
Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat.
Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Cerebrovascular Disorders; Disease Models, Animal; | 1999 |